✨ Free AI Report
Mauna Kea Technologies: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Mauna Kea Technologies
Company Research

Mauna Kea Technologies: Business Overview, Financials & Competitive Analysis

Mauna Kea Technologies manufactures and sells Cellvizio, the real-time in vivo cellular imaging platform that uniquely delivers in vivo cellular visualization enabling physicians to monitor disease progression and ass...

Analyst-debate audio for Mauna Kea Technologies

AskCyborg analysts argue the bull and bear cases for Mauna Kea Technologies across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
4/ 10Mixed

Cyborg Score thesis

Innovative medical imaging technology with strong clinical applications but facing financial restructuring challenges offset by...

Read the full analyst-debate transcript →
Industry Medical Devices - Diagnostic Imaging and Endomicroscopy
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Mauna Kea Technologies Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Mauna Kea Technologies Overview

Pro stress-test →

Mauna Kea Technologies manufactures and sells Cellvizio, the real-time in vivo cellular imaging platform that uniquely delivers in vivo cellular visualization enabling physicians to monitor disease progression and assess reactions as they happen in real time. The company offers a range of medical devices for gastroenterology, pulmonology, and urology applications.

Strategic Profile

Pro stress-test →

The company has obtained regulatory approvals to commercialize its Cellvizio system in Switzerland and the United Kingdom, providing access to strategic European markets recognized for excellence in interventional gastroenterology. Recent organizational changes announced in February 2026 aim to accelerate growth outside the United States by structuring international expansion of both Cellvizio and CellTolerance programs.

Competitive Landscape

Pro stress-test →

Mauna Kea specializes in optical biopsy devices designed for visualizing and detecting cellular abnormalities during gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. The company competes in the medical imaging and diagnostic space with differentiated real-time cellular visualization technology but operates in a niche market with limited direct competitors.

Industry Context

Mauna Kea Technologies operates in Medical Devices - Diagnostic Imaging and Endomicroscopy.

Key facts

Founded: 2000 · Headquarters: Paris, France · Revenue: $9M · Market cap: $27.4M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Mauna Kea Technologies.

  • The company secured firm subscription commitments exceeding €5 million following court approval of its safeguard plan in November 2025.
  • Mauna Kea announced an exclusive U.S. partnership with TaeWoong Medical for pancreatic cyst management, creating an integrated imaging-to-therapy solution designed to enhance clinical accuracy and patient outcomes.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Obtained regulatory clearances in Switzerland and the United Kingdom; announced new organizational structure to accelerate international expansion
  • December 2025Signed exclusive U.S. partnership with TaeWoong Medical for pancreatic cyst management solution
  • +2 moreTrack every material event for Mauna Kea Technologies as it happens. Explore monitoring →
Get alerted when Mauna Kea Technologies has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Endoscopic Imaging SystemsCompetitor in endoscopic imaging and visualization→Advanced Diagnostic ImagingCompetitor in minimally invasive endoscopic solutions→Optical Biopsy SolutionsCompetitor in medical imaging devices→

Compare Mauna Kea Technologies with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Mauna Kea Technologies operates in Medical Devices - Diagnostic Imaging and Endomicroscopy. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - Diagnostic Imaging and Endomicroscopy research →
NEW · MCP server

Ask your AI assistant about Mauna Kea Technologies

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Mauna Kea Technologies and its top competitor on Cyborg Score”
“What did Mauna Kea Technologies do this quarter?”
“Is Mauna Kea Technologies a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Mauna Kea Technologies do?+
Mauna Kea Technologies manufactures and sells Cellvizio, the real-time in vivo cellular imaging platform that uniquely delivers in vivo cellular visualization enabling physicians to monitor disease progression and ass...
What is Mauna Kea Technologies's Cyborg Score?+
Mauna Kea Technologies has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Mauna Kea Technologies's main competitors?+
Named competitors include Endoscopic Imaging Systems, Advanced Diagnostic Imaging, Optical Biopsy Solutions. The full competitive landscape is in the AskCyborg report.
How can I get the full Mauna Kea Technologies research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Mauna Kea Technologies research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Mauna Kea Technologies over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.